Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
256. |
ECCT/20/09/06 | Schisto RDT evaluation A performance evaluation of a prototype rapid diagnostic test for the diagnosis of schistosomiasis |
Principal Investigator(s) 1. Sammy Njenga Site(s) in Kenya Kenya Medical Research Institute (KEMRI) |
View |
257. |
ECCT/20/10/01 | HIV-CORE 006 A Phase 1 Trial of ChAdOx1- and MVA-vectored Conserved Mosaic HIV-1 Vaccines in Healthy, Adult HIV-1-negative Volunteers in Eastern and Southern Africa. |
Principal Investigator(s) 1. Eduard J Sanders Site(s) in Kenya 1. KEMRI Mtwapa Research Clinic (Kilifi county) 2. KAVI-ICR Nairobi (Nairobi City county) |
View |
258. |
ECCT/20/10/02 | MALCOV Malaria as a risk factor for COVID-19 in western Kenya and Burkina Faso (MALCOV) |
Principal Investigator(s) 1. Simon Kariuki 2. Helen Barsosio Site(s) in Kenya 1. Jaramogi Oginga Odinga Teaching and Referral Hospital (JOORTH), (Kisumu county) 2. Kisumu County Referral Hospital. (Kisumu county) 3. Alupe sub-County Hospital, (Busia county) 4. Bondo sub-County Hospital, (Siaya county) 5. Macalder (Nyatike) sub-County Hospital (Migori county) 6. Migori County Teaching and Referral Hospital; (Migori county) |
View |
259. |
ECCT/20/10/03 | Commercial Typhoid tests valid Comparative study of commercially available typhoid point of care tests to benchmark current and emerging tools |
Principal Investigator(s) 1. Robert Sanaya Onsare Site(s) in Kenya 1. Mbagathi County Hospital (Nairobi City county) 2. Medical Missionaries of Mary, Reuben Centre Hospital, Mukuru (Nairobi City county) 3. City Council Clinic, Mukuru (Nairobi City county) |
View |
260. |
ECCT/20/10/04 | yellow fever vaccine CVIA 079 A Phase III double-blind, randomized, active comparator controlled study in healthy Kenyan adolescents, young children and infants to assess the safety and immunogenicity of Beijing Institute of Biologic Products (BIBP) yellow fever vaccine in comparison to a WHO 17D-204 prequalified comparator yellow fever vaccine, as well as lot-to-lot consistency of immune response to the BIBP yellow fever vaccine”, CVIA 079. |
Principal Investigator(s) 1. Dr. Deborah Langat Site(s) in Kenya KEMRI/KERICHO CLINIC RESEARCH CENTRE |
View |